 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| SLITone ULTRA (ragweed allergy vaccine sublingual drops) - ALK / Abello
Enrollment closed: Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis (clinicaltrials.gov) - May 17, 2022
P3, N=445, Active, not recruiting, Sponsor: ALK-Abelló A/S
Recruiting --> Active, not recruiting
- |||||| SLITone ULTRA (ragweed allergy vaccine sublingual drops) - ALK / Abello
Enrollment open: Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis (clinicaltrials.gov) - May 19, 2021
P3, N=440, Recruiting, Sponsor: ALK-Abelló A/S
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- |||||||||| SLITone ULTRA (ragweed allergy vaccine sublingual drops) - ALK / Abello
New P3 trial: Rhapsody: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis (clinicaltrials.gov) - May 11, 2021
P3, N=440, Not yet recruiting, Sponsor: ALK-Abelló A/S
- SLITone ULTRA (ragweed allergy vaccine sublingual drops) - ALK / Abello
Trial completion: A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (clinicaltrials.gov) - Jan 19, 2014
P2, N=219, Completed, Sponsor: ALK-Abelló A/S
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | SLITone ULTRA (ragweed allergy vaccine sublingual drops) - ALK / Abello
New P2 trial: A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (clinicaltrials.gov) - Nov 15, 2012
P2, N=219, Completed, Sponsor: ALK-Abelló A/S